REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Captor Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Basic Organic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | Adhesive Manufacturing | Explosives Manufacturing | All Other Chemical Product and Preparation Manufacturing | Other Miscellaneous Store Retailers | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services
Full name: Captor Therapeutics S.A. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Captor Therapeutics S.A. is an enterprise in Poland, with the main office in Wroclaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on November 07, 2018. The total number of employees is currently 101 - 500 (2025). From the latest financial highlights, Captor Therapeutics S.A. reported a net sales revenue drop of 64.14% in Q3C2025. There was a total negative growth of 49.1% in Captor Therapeutics S.A.’s total assets over the same period. Captor Therapeutics S.A.’s net profit margin decreased by 461.69% in 2025.

Headquarters
ul. Dunska 11
Wroclaw; Dolnoslaskie; Postal Code: 54-427

Contact Details: Purchase the Captor Therapeutics S.A. report to view the information.

Website: http://www.captortherapeutics.com

Basic Information
Total Employees:
Purchase the Captor Therapeutics S.A. report to view the information.
Outstanding Shares:
Purchase the Captor Therapeutics S.A. report to view the information.
Registered Capital:
Purchase the Captor Therapeutics S.A. report to view the information.
Financial Auditors:
Purchase the Captor Therapeutics S.A. report to view the information.
Incorporation Date:
November 07, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
16.49%
Purchase this report to view the information.
10.82%
Purchase this report to view the information.
6.19%
Purchase this report to view the information.
6.16%
Purchase this report to view the information.
6.13%
Company Performance
Financial values in the chart are available after Captor Therapeutics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-64.14%▼
Total Operating Revenue
-25.85%▼
Operating Profit
-10.25%▼
EBITDA
-10.25%▼
Net Profit/Loss for the Period
-7.7%▼
Total Assets
-49.1%▼
Total Equity
-48.4%▼
Operating Profit Margin
-486.35%▼
Net Profit Margin
-461.69%▼
Return on Equity (ROE)
-50.02%▼
Debt / Equity
2.74%▲
Quick Ratio
0.23%▲
Cash Ratio
-1.53%▼

Similar companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
 
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy
Pit-Radwar S.A.
 
Naukowa I Akademicka Siec Komputerowa - Panstwowy Instytut Badawczy
"Novo Nordisk Pharma" Sp. z o.o.
 
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
"Bacto - Tech" Sp. z o.o.
 
Precision For Medicine Pl Sp. z o.o.
Europejski Instytut Biomedyczny Sp. z o.o.
 
Under Ant Sp. z o.o. sp. k.
Enamine Pl Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo